2023 - Research.com Medicine in Finland Leader Award
Her research brings together the fields of Amenorrhea and Genetics. Her work in Amenorrhea is not limited to one particular discipline; it also encompasses Genetics. Internal medicine and Premature ovarian insufficiency are commonly linked in her work. Her research is interdisciplinary, bridging the disciplines of Internal medicine and Premature ovarian insufficiency. She performs multidisciplinary study in the fields of Mutation and Point mutation via her papers. Kristiina Aittomäki performs integrative Point mutation and Mutation research in her work. Her research links Fumarase with Gene. She regularly links together related areas like Gene in her Fumarase studies. Kristiina Aittomäki combines Pregnancy and Live birth in her studies.
Her research on Genetics often connects related topics like Pregnancy. She regularly links together related areas like Genetics in her Pregnancy studies. In her works, she undertakes multidisciplinary study on Gene and Disease. In her works, Kristiina Aittomäki performs multidisciplinary study on Disease and Gene. She incorporates Breast cancer and Cancer research in her studies. She conducted interdisciplinary study in her works that combined Cancer research and Breast cancer. She performs multidisciplinary study in Cancer and Oncology in her work. She merges Oncology with Internal medicine in her study. Her study connects Surgical oncology and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Tomlinson Ip;Alam Na;Rowan Aj;Barclay E.
Nature Genetics (2002)
MUTATION IN THE FOLLICLE-STIMULATING HORMONE RECEPTOR GENE CAUSES HEREDITARY HYPERGONADOTROPIC OVARIAN FAILURE
Kristiina Aittomäki;Kristiina Aittomäki;JoséLuis Dieguez Lucena;JoséLuis Dieguez Lucena;Pirjo Pakarinen;Pertti Sistonen.
RAD51B in Familial Breast Cancer
Liisa M. Pelttari;Sofia Khan;Mikko Vuorela;Johanna I. Kiiski.
PLOS ONE (2016)
Association analysis identifies 65 new breast cancer risk loci
Kyriaki Michailidou;Kyriaki Michailidou;Sara Lindström;Sara Lindström;Joe Dennis;Jonathan Beesley.
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou;S. Casadei;T. Heikkinen;D. Barrowdale.
The New England Journal of Medicine (2014)
Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta-analysis
A Pinborg;U B Wennerholm;L B Romundstad;A Loft.
Human Reproduction Update (2013)
MicroRNA related polymorphisms and breast cancer risk
Sofia Khan;Dario Greco;Dario Greco;Kyriaki Michailidou;Roger L. Milne;Roger L. Milne.
PLOS ONE (2014)
Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek.
Cancer Epidemiology, Biomarkers & Prevention (2012)
Men Homozygous for an Inactivating Mutation of the Follicle-Stimulating Hormone (FSH) Receptor Gene Present Variable Suppression of Spermatogenesis and Fertility
Juha S. Tapanainen;Kristiina Aittomäki;Kristiina Aittomäki;Jiang Min;Tommi Vaskivuo.
Nature Genetics (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: